The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples